JMP Securities lowered the firm’s price target on Ibotta (IBTA) to $85 from $111 and keeps an Outperform rating on the shares. Ibotta ...
In a report released today, Mark Mahaney from Evercore ISI maintained a Buy rating on Ibotta, Inc. Class A (IBTA – Research Report), with ...
Inovio Pharmaceuticals (NASDAQ: INO) Q3 2024 Earnings Call Nov 14, 2024, 4:30 p.m. ET ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback